Trials / Completed
CompletedNCT03861533
GOAL International QuERI - Protocol CHRC 2019 GOAL INTERNATIONAL
Guidelines Oriented Approach to Lipid Lowering Quality Enhancement Research Initiative (GOAL QuERI) International
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,422 (actual)
- Sponsor
- Dr. Anatoly Langer · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This Quality Enhancement Research Initiative (QuERI) is a knowledge translation medical practice activity based on decision making support through feedback to physicians on their management of dyslipidemia in order to achieve guidelines recommended LDL-C levels in high risk patients. Physician interaction has three distinct components: 1. Capture of data as reported by participating physician; 2. Highlight (by providing feedback) where management may be optimized based on guidelines or recommendations; 3. Identify challenges faced by physicians resulting in the care gap..
Detailed description
The GOAL QuERI International will engage approximately 115 health care practitioners (HCP) who will enroll up to 2500 patients with management observations based on four visits by the patients in an outpatient setting. The timing of the visits will be baseline, 6±2 months, 12±2 months, and 18±2 months during which patient management by their physician will be captured using the electronic data capture form (DCF). The DCF will be created and managed by the CHRC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | survey | Cross-Reference |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2019-03-04
- Last updated
- 2024-08-22
Locations
4 sites across 4 countries: Kuwait, Mexico, Saudi Arabia, United Arab Emirates
Source: ClinicalTrials.gov record NCT03861533. Inclusion in this directory is not an endorsement.